Rapid induction of apoptosis mediated by peptides that bind initiation factor eIF4E
- PMID: 10898981
- DOI: 10.1016/s0960-9822(00)00567-4
Rapid induction of apoptosis mediated by peptides that bind initiation factor eIF4E
Abstract
Overexpression of the translation initiation factor eIF4E leads to cell transformation and occurs in a number of human cancers [1]. mRNA translation and cell growth can be regulated through the availability of eIF4E to form initiation complexes by binding to eIF4G. The availability of eIF4E is blocked through the binding of members of a family of eIF4E-binding proteins (4E-BPs) [2] [3]. Indeed, cell transformation caused by the overexpression of eIF4E can be reversed by the overexpression of 4E-BPs [4] [5] [6] [7] [8]. To study the role of eIF4E in cell transformation, we developed a series of peptides based on the conserved eIF4E-binding motifs in 4E-BPs and eIF4G [9] linked to the penetratin peptide-carrier sequence, which mediates the rapid transport of peptides across cell membranes. Surprisingly, introduction of these eIF4E-binding peptides into MRC5 cells led to rapid, dose-dependent cell death, with characteristics of apoptosis. Single alanine substitutions at key positions in the peptides impair their binding to eIF4E and markedly reduce their ability to induce apoptosis. A triple alanine substitution, which abolishes binding to eIF4E, renders the peptide unable to induce apoptosis. Our data provide strong evidence that the peptides induce apoptosis through binding to eIF4E. They do not induce apoptosis through inhibition of protein synthesis, as chemical inhibitors of translation did not induce apoptosis or affect peptide-induced cell death. Thus these new data indicate that eIF4E has a direct role in controlling cell survival that is not linked to its known role in mRNA translation.
Similar articles
-
Repressor binding to a dorsal regulatory site traps human eIF4E in a high cap-affinity state.EMBO J. 1999 Jul 15;18(14):4068-75. doi: 10.1093/emboj/18.14.4068. EMBO J. 1999. PMID: 10406811 Free PMC article.
-
Molecular architecture of 4E-BP translational inhibitors bound to eIF4E.Mol Cell. 2015 Mar 19;57(6):1074-1087. doi: 10.1016/j.molcel.2015.01.017. Epub 2015 Feb 19. Mol Cell. 2015. PMID: 25702871
-
Biophysical studies of eIF4E cap-binding protein: recognition of mRNA 5' cap structure and synthetic fragments of eIF4G and 4E-BP1 proteins.J Mol Biol. 2002 Jun 7;319(3):615-35. doi: 10.1016/S0022-2836(02)00328-5. J Mol Biol. 2002. PMID: 12054859
-
Translational regulation in cell stress and apoptosis. Roles of the eIF4E binding proteins.J Cell Mol Med. 2001 Jul-Sep;5(3):221-39. doi: 10.1111/j.1582-4934.2001.tb00157.x. J Cell Mol Med. 2001. PMID: 12067482 Free PMC article. Review.
-
Control of the eIF4E activity: structural insights and pharmacological implications.Cell Mol Life Sci. 2021 Nov;78(21-22):6869-6885. doi: 10.1007/s00018-021-03938-z. Epub 2021 Sep 19. Cell Mol Life Sci. 2021. PMID: 34541613 Free PMC article. Review.
Cited by
-
EGFR targeting monoclonal antibody combines with an mTOR inhibitor and potentiates tumor inhibition by acting on complementary signaling hubs.Cancer Med. 2012 Oct;1(2):114-27. doi: 10.1002/cam4.21. Epub 2012 Aug 1. Cancer Med. 2012. PMID: 23342262 Free PMC article.
-
Novel cap analogs for in vitro synthesis of mRNAs with high translational efficiency.RNA. 2004 Sep;10(9):1479-87. doi: 10.1261/rna.7380904. RNA. 2004. PMID: 15317978 Free PMC article.
-
The role of olefin geometry in the activity of hydrocarbon stapled peptides targeting eukaryotic translation initiation factor 4E (eIF4E).Org Biomol Chem. 2019 Jul 14;17(26):6414-6419. doi: 10.1039/c9ob01041f. Epub 2019 Jun 19. Org Biomol Chem. 2019. PMID: 31215581 Free PMC article.
-
Therapeutic Opportunities in Eukaryotic Translation.Cold Spring Harb Perspect Biol. 2018 Jun 1;10(6):a032995. doi: 10.1101/cshperspect.a032995. Cold Spring Harb Perspect Biol. 2018. PMID: 29440069 Free PMC article. Review.
-
Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity.J Clin Invest. 2007 Sep;117(9):2638-48. doi: 10.1172/JCI32044. J Clin Invest. 2007. PMID: 17786246 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources